Urinary biomarkers of environmental exposures and asthma morbidity in a school inner city asthma study

Marissa Hauptman1, Medina S Jackson-Browne2, Stefanie Busgang3

  • 1Division of General Pediatrics, Boston Children's Hospital, Boston, MA, USA; Region 1 New England Pediatric Environmental Health Specialty Unit, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.

Insights

Urinary biomarkers showed an inverse association with pediatric asthma symptoms in inner-city children, with varying effects based on race and ethnicity. These findings suggest potential benefits from certain environmental chemical exposures.

Area of Science:

  • Environmental health
  • Pediatric allergy
  • Toxicology

Background:

  • Pediatric asthma burden is unequally distributed across US populations.
  • Inner-city children face a disproportionate risk of asthma and allergic diseases.
  • Understanding environmental factors is crucial for addressing health disparities.

Purpose of the Study:

  • To investigate the association between urinary biomarkers and asthma morbidity in children.
  • To examine if these associations differ by child race, ethnicity, and sex.
  • To explore the impact of environmental chemical exposures on pediatric asthma.

Main Methods:

  • 152 children with asthma from the School Inner-City Asthma Intervention Study (SICAS-2) were analyzed.
  • Urinary metabolites of phenols, parabens, PAHs, and phthalates were measured.
  • Weighted quantile sum regression models assessed chemical mixtures, controlling for covariates and analyzing effect modification by race/ethnicity.

Main Results:

  • Participants were predominantly Hispanic/Latino and low-income.
  • Significant interaction effects were observed, with differing analyte contributions based on allergen sensitivity.
  • Reduced odds of asthma symptoms were noted in children of "other" races/ethnicities compared to Black, Non-Hispanic children.

Conclusions:

  • Preliminary findings indicate an inverse association between environmental chemical exposure and asthma symptoms in inner-city children.
  • This inverse association may be linked to personal care product and medication use.
  • Further research is needed to fully elucidate the beneficial effects observed for most chemicals.
Abstract

Related Concept Videos

Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
2.5K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K